Medicare beneficiaries spent $1.7 billion out of pocket on the 15 drugs. The negotiated price reductions may save beneficiaries $685 million in out-of-pocket costs.
Medicare beneficiaries spent $1.7 billion out of pocket on the 15 drugs. The negotiated price reductions may save beneficiaries $685 million in out-of-pocket costs.